Literature DB >> 27620828

Improved Diagnosis of Inherited Retinal Dystrophies by High-Fidelity PCR of ORF15 followed by Next-Generation Sequencing.

Jianli Li1, Jia Tang2, Yanming Feng1, Mingchu Xu3, Rui Chen3, Xuan Zou4, Ruifang Sui4, Emmanuel Y Chang5, Richard A Lewis6, Victor W Zhang3, Jing Wang3, Lee-Jun C Wong7.   

Abstract

Retinitis pigmentosa (RP) is the most common form of retinal dystrophy. The disease is characterized by the progressive degeneration of photoreceptors, ultimately leading to blindness. The exon ORF15 of RP GTPase regulator (RPGR) is a mutation hot spot for X-linked RP and one form of cone dystrophy. However, accurate molecular testing of ORF15 is challenging because of a large segment of highly repetitive purine-rich sequence in this exon. ORF15 performs poorly in next-generation sequencing-based panels or whole exome sequencing analysis, whereas Sanger sequencing of ORF15 requires special reagents and PCR conditions with multiple pairs of overlapping primers that often do not provide a clean sequence. Because of these technical difficulties, molecular analysis of ORF15 is performed mostly in research laboratories without validation for clinical application. Herein, we report the development of a single step of high-fidelity PCR followed by next-generation sequencing for accurate mutation detection, which is easily integrated into routine clinical practice. Our approach has improved coverage depth of ORF15 with the ability to detect single-nucleotide variants and deletions/duplications. Using this method, we were able to identify ORF15 pathogenic variants in approximately 31% of undiagnosed RP patients. Our results underline the clinical importance of complete and accurate sequence analysis of ORF15 for patients with retinal dystrophies.
Copyright © 2016 American Society for Investigative Pathology and the Association for Molecular Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27620828     DOI: 10.1016/j.jmoldx.2016.06.007

Source DB:  PubMed          Journal:  J Mol Diagn        ISSN: 1525-1578            Impact factor:   5.568


  10 in total

1.  Variegated yet non-random rod and cone photoreceptor disease patterns in RPGR-ORF15-associated retinal degeneration.

Authors:  Jason Charng; Artur V Cideciyan; Samuel G Jacobson; Alexander Sumaroka; Sharon B Schwartz; Malgorzata Swider; Alejandro J Roman; Rebecca Sheplock; Manisha Anand; Marc C Peden; Hemant Khanna; Elise Heon; Alan F Wright; Anand Swaroop
Journal:  Hum Mol Genet       Date:  2016-12-15       Impact factor: 6.150

2.  Inherited Retinal Disease Panels-Caveat Emptor-Truly Know Your Inherited Retinal Disease Panel.

Authors:  Jose S Pulido; Rebecca Procopio; Hiram J Davila; Nicholas Bello; Cristy Ku; Mark E Pennesi; Paul Yang; Aaron Nagiel; Omar A Mahroo; Tomas S Aleman; Ezequiel M Salido; Margaret Reynolds
Journal:  Retina       Date:  2022-01-01       Impact factor: 4.256

3.  Target 5000: Target Capture Sequencing for Inherited Retinal Degenerations.

Authors:  Adrian Dockery; Kirk Stephenson; David Keegan; Niamh Wynne; Giuliana Silvestri; Peter Humphries; Paul F Kenna; Matthew Carrigan; G Jane Farrar
Journal:  Genes (Basel)       Date:  2017-11-03       Impact factor: 4.096

4.  Extensive genic and allelic heterogeneity underlying inherited retinal dystrophies in Mexican patients molecularly analyzed by next-generation sequencing.

Authors:  Juan C Zenteno; Leopoldo A García-Montaño; Marisa Cruz-Aguilar; Josué Ronquillo; Agustín Rodas-Serrano; Luis Aguilar-Castul; Rodrigo Matsui; Carlos I Vencedor-Meraz; Rocío Arce-González; Federico Graue-Wiechers; Mario Gutiérrez-Paz; Tatiana Urrea-Victoria; Ulises de Dios Cuadras; Oscar F Chacón-Camacho
Journal:  Mol Genet Genomic Med       Date:  2019-11-17       Impact factor: 2.183

5.  Spectrum of Disease Severity in Patients With X-Linked Retinitis Pigmentosa Due to RPGR Mutations.

Authors:  Valentina Di Iorio; Marianthi Karali; Paolo Melillo; Francesco Testa; Raffaella Brunetti-Pierri; Francesco Musacchia; Christel Condroyer; John Neidhardt; Isabelle Audo; Christina Zeitz; Sandro Banfi; Francesca Simonelli
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-12-01       Impact factor: 4.799

6.  Long-Range PCR-Based NGS Applications to Diagnose Mendelian Retinal Diseases.

Authors:  Jordi Maggi; Samuel Koller; Luzy Bähr; Silke Feil; Fatma Kivrak Pfiffner; James V M Hanson; Alessandro Maspoli; Christina Gerth-Kahlert; Wolfgang Berger
Journal:  Int J Mol Sci       Date:  2021-02-03       Impact factor: 5.923

7.  Prevalence of RPGR-Mediated Retinal Dystrophy in an Unselected Cohort of Over 5000 Patients.

Authors:  Sari Tuupanen; Kimberly Gall; Johanna Sistonen; Inka Saarinen; Kati Kämpjärvi; Kirsty Wells; Katja Merkkiniemi; Pernilla von Nandelstadh; Laura Sarantaus; Johanna Känsäkoski; Emma Mårtenson; Hanna Västinsalo; Jennifer Schleit; Eeva-Marja Sankila; Annakarin Kere; Heidi Junnila; Pauli Siivonen; Margarita Andreevskaya; Ville Kytölä; Mikko Muona; Pertteli Salmenperä; Samuel Myllykangas; Juha Koskenvuo; Tero-Pekka Alastalo
Journal:  Transl Vis Sci Technol       Date:  2022-01-03       Impact factor: 3.283

8.  Genotype-Phenotype Analysis of RPGR Variations: Reporting of 62 Chinese Families and a Literature Review.

Authors:  Junxing Yang; Lin Zhou; Jiamin Ouyang; Xueshan Xiao; Wenmin Sun; Shiqiang Li; Qingjiong Zhang
Journal:  Front Genet       Date:  2021-06-23       Impact factor: 4.599

9.  De Novo Assembly-Based Analysis of RPGR Exon ORF15 in an Indigenous African Cohort Overcomes Limitations of a Standard Next-Generation Sequencing (NGS) Data Analysis Pipeline.

Authors:  Jordi Maggi; Lisa Roberts; Samuel Koller; George Rebello; Wolfgang Berger; Rajkumar Ramesar
Journal:  Genes (Basel)       Date:  2020-07-15       Impact factor: 4.096

10.  A new approach based on targeted pooled DNA sequencing identifies novel mutations in patients with Inherited Retinal Dystrophies.

Authors:  Maitane Ezquerra-Inchausti; Ander Anasagasti; Olatz Barandika; Gonzaga Garay-Aramburu; Marta Galdós; Adolfo López de Munain; Cristina Irigoyen; Javier Ruiz-Ederra
Journal:  Sci Rep       Date:  2018-10-18       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.